After long road to approval, Teva and Alvotech believe their Humira biosimilar Simlandi may have an edge

Teva and Alvotech have braved a long and winding road on the quest to win approval for their biosimilar to AbbVie’s Humira. Now, after multiple manufacturing setbacks, the partners have finally scored their inaugural regulatory nod in the United States.